Abstract
Objective Why are Americans COVID-19 vaccine hesitant? We test social science hypotheses for vaccine hesitancy, focusing on partisanship, trust in institutions, and social-demographic characteristics of registered voters.
Methods We use survey data from a representative sample of American registered voters collected in November 2020 to study vaccine hesitancy, and the reasons for vaccine hesitancy, at a point in time before the vaccine was available and hence show underlying responses based on beliefs and not on clinical trial data. We use multivariate logistic regression models to test hypotheses on vaccine hesitancy.
Results We find that consistently similar groups of people tend to be vaccine hesitant. Specifically, Black voters, those between the ages of 45 and 64, female voters, voters without college degrees, voters not worried about the spread of COVID-19, and voters who are concerned about government and the CDC’s handling of the COVID-19 pandemic, were vaccine hesitant. We also provide intriguing results showing the nuanced reasons that the vaccine hesitant provide.
Conclusions Our analysis allows us to establish important baseline information from a social science perspective on vaccine hesitancy at a crucial time, right before COVID-19 vaccines were beginning to be made available to adult Americans. What emerges from our analysis is a nuanced perspective on vaccine hesitancy in the United States, from this important point in the history of the COVID-19 pandemic.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The data used is in this study were supported by funding from the John Randolph Haynes Foundation.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of Caltech determined the research was exempt.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and code will be available upon publication.
